Literature DB >> 2017689

Antithrombin: structure and function.

C W Pratt1, F C Church.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2017689

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

Review 1.  Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients.

Authors:  Hwa Jin Cho; Do Wan Kim; Gwan Sic Kim; In Seok Jeong
Journal:  Chonnam Med J       Date:  2017-05-25

2.  Suggestions on leading an academic research laboratory group.

Authors:  Frank C Church
Journal:  Open Life Sci       Date:  2022-06-15       Impact factor: 1.311

3.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

5.  Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial.

Authors:  Mauro Panigada; Elena Spinelli; Alberto Cucino; Elisa Cipriani; Stefano De Falco; Giovanna Panarello; Giovanna Occhipinti; Antonio Arcadipane; Gabriele Sales; Vito Fanelli; Luca Brazzi; Cristina Novembrino; Dario Consonni; Antonio Pesenti; Giacomo Grasselli
Journal:  Trials       Date:  2019-06-11       Impact factor: 2.279

Review 6.  Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children.

Authors:  Madhuradhar Chegondi; Niranjan Vijayakumar; Balagangadhar R Totapally
Journal:  Pediatr Rep       Date:  2022-07-11

7.  Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation.

Authors:  Heiko Sorg; Julius O Hoffmann; Johannes N Hoffmann; Brigitte Vollmar
Journal:  Intensive Care Med Exp       Date:  2015-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.